In the Journals

Remicade is top among biologic-naive patients with UC

January 16, 2020
Remicade ranked highest for induction of remission and endoscopic improvement among biologic-naive patients, according to a meta-analysis of…

Editorial

Looking Back at 2019’s Top 10, Peer Tested by You

Healio Gastroenterology, January 2020
Edward V. Loftus Jr., MD
As we enter the 6th year of Healio Gastroenterology and Liver Disease, it is worth looking back at what made us stand out in 2019: the Peer Tested…

In the Journals

JAK inhibitors may increase risk for herpes zoster in patients with IBD

January 15, 2020
Patients with inflammatory bowel disease and other immune-mediated diseases who receive Janus kinase inhibitors may be at increased risk for herpes…

Feature

Expert raises awareness of misunderstood GI symptoms following Pat Sajak’s health scare

January 13, 2020
Tonight, Jan. 13, Pat Sajak is expected to make his permanent return to Wheel of Fortune. The 73-year-old’s hosting schedule had been sporadic…

Meeting News

Highlights from AIBD 2019

January 11, 2020
Healio Gastroenterology and Liver Disease presents some of the top stories from Advances in Inflammatory Bowel Disease 2019. The meeting focused on…

In the Journals

IBD associated with gestational diabetes, other poor pregnancy outcomes

January 10, 2020
Pregnant women with inflammatory bowel disease were more likely to have a cesarean delivery and experience certain adverse pregnancy outcomes…

In the Journals

One-third of pregnant women with IBD experience postpartum flares

January 9, 2020
Women with inflammatory bowel disease maintain a moderate risk for disease relapse, including flares, in the year after they give birth, according to…

In the Journals

Mediterranean diet linked with lower risk for late-onset Crohn’s

January 8, 2020
Individuals who adhere to a Mediterranean diet are at lower risk for developing Crohn’s disease later in life, according to study results…

In the Journals

Low-FODMAP diet helps manage gut symptoms in quiescent IBD

January 6, 2020
Although patients with inflammatory bowel disease may have their disease in objective control, many still experience persistent gut symptoms. A diet…

By the Numbers

7 Recent reports in IBD

December 31, 2019
Healio Gastroenterology and Liver Disease presents the following reports on the most recent research on inflammatory bowel disease These reports…

In the Journals

Treat-to-target measured by ultrasonography linked with better Crohn’s outcomes

December 31, 2019
Small intestine contrast ultrasonographic assessment of mucosal healing can be an effective method to gauge response to anti-TNF therapy among…

In the Journals

Inpatient opioids linked with future opioid use in IBD

December 30, 2019
Patients who received intravenous or non-intravenous opioids while in the hospital are more likely to be exposed to opioids after they are…

In the Journals

Intestinal ultrasound helps monitor response in ulcerative colitis

December 30, 2019
Assessing bowel wall thickness with intestinal ultrasound can be a helpful tool to monitor therapeutic response in patients with ulcerative colitis…

In the Journals

Switch to Entyvio after calcineurin inhibitor induction safe, effective for ulcerative colitis

December 27, 2019
Transitioning to Entyvio after achieving induction of remission with calcineurin inhibitor therapy is safe and effective for patients with ulcerative…

In the Journals

Anti-TNF alpha not linked with recurrent, new primary cancers in IBD

December 26, 2019
Patients with inflammatory bowel disease and other immune-mediate diseases treated with anti-TNF alpha who previously had cancer are not at greater…

Meeting News

Pregnancy presents additional challenges in IBD

December 26, 2019
ORLANDO — Pregnancy has the potential to present some difficult medical scenarios for women with inflammatory bowel disease. Sunanda V. Kane

Meeting News

All C. difficile tests not created equal, especially among patients with IBD

December 19, 2019
ORLANDO — Identifying Clostridioides difficile infection among patients with inflammatory bowel disease can be a particularly tricky task…

Cover Story

Therapeutic Drug Monitoring: Empirical Evidence Catches up to Common Sense

Healio Gastroenterology, December 2019
Common sense might dictate that, in maintaining health and wellness, being proactive is generally better than being reactive. But the practice of…

Guest Commentary

Q&A: Navigating Proactive, Reactive TDM in a Private Practice Setting

Healio Gastroenterology, December 2019
Sushama Gundlapalli, MD, MS
Differentiating patients with inflammatory bowel disease who have lost response to a biologic used to be considered a “gray zone,”…

Meeting News

Testing for loss of response could shape future IBD care

December 18, 2019
ORLANDO — Adding genetic testing to the management of patients with inflammatory bowel disease may present an opportunity to determine which…